National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

OBJECTIVES: Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasseli, Rebecca, Mueller-Ladner, Ulf, Schmeiser, Tim, Hoyer, Bimba F, Krause, Andreas, Lorenz, Hanns-Martin, Regierer, Anne Constanze, Richter, Jutta G, Strangfeld, Anja, Voll, Reinhard E, Pfeil, Alexander, Schulze-Koops, Hendrik, Specker, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507994/
https://www.ncbi.nlm.nih.gov/pubmed/32878994
http://dx.doi.org/10.1136/rmdopen-2020-001332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507994/
https://www.ncbi.nlm.nih.gov/pubmed/32878994
http://dx.doi.org/10.1136/rmdopen-2020-001332

Ejemplares similares